NEWS

Creating new life to save endangered life – Digital Journal

Fred Hutch researchers engineer complex immunotherapy that may target relapsing leukemia – Medical Xpress

Medical XpressFred Hutch researchers engineer complex immunotherapy that may target relapsing leukemiaMedical XpressThe findings, published online in the journal Blood, provide the basis for launching a first-in-human clinical trial of this new immunot… Continue reading

Fred Hutch researchers engineer complex immunotherapy that may target relapsing leukemia – Medical Xpress

Medical XpressFred Hutch researchers engineer complex immunotherapy that may target relapsing leukemiaMedical XpressThe findings, published online in the journal Blood, provide the basis for launching a first-in-human clinical trial of this new immunot… Continue reading

Immunotherapy Makes a Difference in Relapsed Hodgkin Lymphoma – Targeted Oncology

Immunotherapy Makes a Difference in Relapsed Hodgkin LymphomaTargeted OncologyBriones, chief of the Hematology Service, Hospital de la Santa Creu i Sant Pau in Barcelona, Spain, discussed the rationale for treating patients with Hodgkin lymphoma with … Continue reading

Immunotherapy Makes a Difference in Relapsed Hodgkin Lymphoma – Targeted Oncology

Immunotherapy Makes a Difference in Relapsed Hodgkin LymphomaTargeted OncologyBriones, chief of the Hematology Service, Hospital de la Santa Creu i Sant Pau in Barcelona, Spain, discussed the rationale for treating patients with Hodgkin lymphoma with … Continue reading

Agency Debuts Gene Therapy Division – O’Dwyer’s PR News

O’Dwyer’s PR NewsAgency Debuts Gene Therapy DivisionO’Dwyer’s PR NewsHealthcare communications shop The Ruth Group has launched a new specialized practice dedicated solely to the gene therapy and gene editing sector. The newly assembled unit, which is … Continue reading

Chimeric Antigen Receptor T-Cell Therapy in Acute Myeloid Leukemia – Targeted Oncology

Chimeric Antigen Receptor T-Cell Therapy in Acute Myeloid LeukemiaTargeted OncologyChimeric antigen receptor (CAR) T-cell therapy is a novel form of cellular immunotherapy in which autologous T cells are genetically modified to express CARs found on tu… Continue reading